Recognizing rosacea. Could you be misdiagnosing this common skin disorder?

Postgraduate Medicine

Volumn 105, Issue 2, 1999, Pages 149-158

  Millikan, Larry ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VULGARIS; CLINICAL FEATURE; CONTACT DERMATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FOLLICULITIS; HUMAN; LASER SURGERY; PATIENT COUNSELING; PERIORAL DERMATITIS; REVIEW; RISK FACTOR; ROSACEA; SEBORRHEIC DERMATITIS; FACE; PATHOLOGY; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; SKIN;

ANTIINFECTIVE AGENT;

ANTI-INFECTIVE AGENTS; DIAGNOSIS, DIFFERENTIAL; FACE; HUMANS; PATIENT EDUCATION; ROSACEA; SKIN;

EID: 0033062457     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1999.02.549     Document Type: Review

References (16)

1. Kligman AM. Ocular rosacea: current concepts and therapy. (Editorial) Arch Dermatol 1997;133(1):89-90
2. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol 1989;69(5):419-23
3. Browning DJ, Rosenwasser G, Lugo M. Ocular rosacea in blacks. Am J Ophthalmol 1986;101(4):441-4
4. Sibenge S, Gawkrodger DJ. Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol 1992;26(4):590-3
5. Drolet B, Paller AS. Childhood rosacea. Pediatr Dermatol 1992;9(1):22-6
6. Thiboutot DM. Acne rosacea. Am Fam Physician 1994;50(8):1691-7, 1701-2
7. Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol 1993;28(3):443-8
8. Dahl M, ed. Rosacea: diagnosis and treatment. In: Perspectives. Minnetonka, Minn: Mark Dahl & Associates, 1996
9. Browning DJ, Proia AD. Ocular rosacea. Surv Ophthalmol 1986;31(3):145-58
10. Aronson IK, Rumsfield JA, West DP, et al. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharm 1987;21(4):346-51
11. Dahl MV, Katz HI, Krueger GG, et al. Topical metronidajole maintains remissions of rosacea. Poster presented at: American Academy of Dermatology; March 21-26, 1997; San Francisco
12. James W, Dahl M, Sober A, et al. Psychological impact of rosacea may be more severe than physical condition. Cosmetic Dermatol 1997;10:27-30
13. Wilkin JK. Vasodilator rosacea. Arch Dermatol 1980;116(5):598
14. Gilleaudeau P, Vallat VP, Carter DM, et al. Angiotensin-converting enzyme inhihitors as possible exacerbating drugs in psoriasis. J Am Acad Dermatol 1993;28(3):490-2
15. Litt JZ, Pawlak WA Jr. Drug eruption reference manual. New York: Parthenon Publishing, 1997
16. Berg M, Liden S. Postmenopausal female rosacea patients are more disposed to react with migraine. (Letter) Dermatology 1996;193(1):73-4